Elicio Therapeutics share price today

(ELTX)

Elicio Therapeutics share price is $4.88 & ₹414.68 as on 21 Dec 2024, 2.30 'hrs' IST

$4.88

▲

-0.2

(-3.84%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Elicio Therapeutics share price in Dollar and Rupees. Guide to invest in Elicio Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Elicio Therapeutics. Get details on the Indian mutual funds that are investing in Elicio Therapeutics. Get Analyst recommendations and forecasts along with all the Elicio Therapeutics's financials.

Elicio Therapeutics share price movements

Today's Low: $4.70
Today's High: $5.02
$4.88
3.69%
Downside
Day's Volatility :6.37%
Upside
2.79%
52 Weeks Low: $2.96
52 Weeks High: $11.45
$4.88
39.34%
Downside
52 Weeks Volatility :74.15%
Upside
57.38%

Elicio Therapeutics Returns

Period	Elicio Therapeutics Inc	Index (Russel 2000)
3 Months	-2.01%	0.0%
6 Months	-31.65%	0.0%
1 Year	-24.34%	0.0%
3 Years	84.15%	-19.7%

Elicio Therapeutics Key Statistics

in dollars & INR

Previous Close	$5.075
Open	$5.0
Today's High	$5.02
Today's Low	$4.7
Market Capitalization	$54.8M
Today's Volume	$25.3K
52 Week High	$11.45
52 Week Low	$2.96
Revenue TTM	$0.0
EBITDA	$-41.0M
Earnings Per Share (EPS)	$-3.44
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-353.02%

How to invest in Elicio Therapeutics from India?

It is very easy for Indian residents to invest directly in Elicio Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Elicio Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Elicio Therapeutics or ELTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Elicio Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Elicio Therapeutics shares which would translate to 0.174 fractional shares of Elicio Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Elicio Therapeutics, in just a few clicks!

Returns in Elicio Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Elicio Therapeutics investment value today

Current value as on today

₹1,26,537

Returns

₹26,537

(+26.54%)

Returns from Elicio Therapeutics Stock

₹24,341 (false-24.34%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Elicio Therapeutics

-48%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Elicio Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -48% less investors are searching Elicio Therapeutics in the last 30 days versus the previous period.

Analyst Recommendation on Elicio Therapeutics

Buy

75%Buy

25%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Elicio Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Elicio Therapeutics

What analysts predicted

Upside of 94.67%

Current:

$4.88

Target:

$9.50

Insights on Elicio Therapeutics

Price Movement
In the last 3 years, ELTX stock has moved up by 80.7%
ELTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 51.4%

Elicio Therapeutics Technicals Summary

Sell

Neutral

Buy

Elicio Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Elicio Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Elicio Therapeutics Inc	-4.69%	-31.65%	-24.34%	84.15%	-71.33%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Elicio Therapeutics Inc	5.75	NA	NA	-4.07	-3.53	-0.97	NA	1.18
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Elicio Therapeutics Inc	Buy	$54.8M	-71.33%	5.75	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Elicio Therapeutics

elicio is committed to transforming the lives of patients and their families by re-engineering the body’s immune response to cancer. by combining expertise in materials science and immunology, elicio is engineering potent vaccines and immuno-therapies for an array of aggressive cancers. the elicio amphiphile platform enables precise targeting and delivery of immunogens directly to the lymphatic system, the “brain center” of the immune response, to significantly amplify and enhance the body’s own system of defenses, to defeat cancer and stop its recurrence. this substantially enhanced anti-tumor functionality and long-term protective memory could unlock the full potential of the human immune response to eliminate cancer. elicio's lead amphiphile vaccines targeting pancreatic, colorectal, and head and neck cancer will begin initial patient studies in early 2020. elicio was founded to expand and apply the ground-breaking amphiphile technology invented and developed in the labs of darrell

Organization	Elicio Therapeutics
Employees	32
CEO	Mr. Robert T. Connelly
Industry	Miscellaneous

Management People of Elicio Therapeutics

Name	Title
Mr. Robert T. Connelly	CEO, President, Principal Accounting Officer, Principal Financial Officer & Director
Dr. Christopher M. Haqq M.D., Ph.D.	Executive VP, Head of Research & Development and Chief Medical Officer
Prof. Darrell J. Irvine Ph.D.	Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board
Mr. Michael DiVecchia	Senior Vice President of Operations & Human Resources
Dr. Peter DeMuth Ph.D.	Chief Scientific Officer
Ms. Megan C. Filoon	General Counsel, Secretary & Compliance Officer
Ms. Esther Welkowsky	Senior Vice President of Clinical Development
Ms. Joy Seymour	VP & Head of Regulatory Affairs
Dr. Thian Kheoh Ph.D.	Senior Vice President of Biometrics

Important FAQs about investing in Elicio Therapeutics from India :

What is Elicio Therapeutics share price today?

Elicio Therapeutics share price today stands at $4.88, Open: $5.00 ; Previous Close: $5.08 ; High: $5.02 ; Low: $4.70 ; 52 Week High: $11.45 ; 52 Week Low: $2.96. The stock opens at $5.00, after a previous close of $5.08. The stock reached a daily high of $5.02 and a low of $4.70, with a 52-week high of $11.45 and a 52-week low of $2.96.

Can Indians buy Elicio Therapeutics shares?

Yes, Indians can invest in the Elicio Therapeutics (ELTX) from India.

With INDmoney, you can buy Elicio Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Elicio Therapeutics at zero transaction cost.

How can I buy Elicio Therapeutics shares from India?

It is very easy to buy Elicio Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Elicio Therapeutics be purchased?

Yes, you can buy fractional shares of Elicio Therapeutics with INDmoney app.

What are the documents required to start investing in Elicio Therapeutics stocks?

To start investing in Elicio Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.